Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Exp Eye Res. 2022 Mar 24;219:109039. doi: 10.1016/j.exer.2022.109039

Table 1:

Experimental group names alongside a brief description of the visual experience and treatment received by each group.

Group Description
Normal Normal visual experience with no retrobulbar injections (n=5)
FD-alone FD treatment with no retrobulbar injections (n=5)
FD+5×sham FD treatment with 5 retrobulbar buffer injections at 0 mM(n=5)
FD+3×10mM GEN FD treatment with 3 retrobulbar genipin injections at 10 mM (n=5)
FD+3×20mM GEN FD treatment with 3 retrobulbar genipin injections at 20 mM (n=5)
FD+5×20mM GEN FD treatment with 5 retrobulbar genipin injections at 20 mM (n=5)